The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study

BACKGROUND: Numerous studies have investigated the potential association of sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) with an increased risk of lower limb amputations (LLAs), but have produced conflicting results. Particularly studies comparing SGLT2-Is to glucagon-like peptide-1 recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Werkman, Nikki C. C., Driessen, Johanna H. M., Stehouwer, Coen D. A., Vestergaard, Peter, Schaper, Nicolaas C., van den Bergh, Joop P., Nielen, Johannes T. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311702/
https://www.ncbi.nlm.nih.gov/pubmed/37386427
http://dx.doi.org/10.1186/s12933-023-01897-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311702/
https://www.ncbi.nlm.nih.gov/pubmed/37386427
http://dx.doi.org/10.1186/s12933-023-01897-2

Ejemplares similares